Evaluation of neuropsychological outcome and “quality of life” after glioma surgery

[1] Stummer W(2006)Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 392-401

[2] Pichlmeier U(2012)The challenge to remove diffuse low-grade gliomas while preserving brain functions Acta Neurochir (Wien) 154 569-574

[3] Meinel T(2008)Glioma extent of resection and its impact on patient outcome Neurosurgery 62 753-764

[4] Duffau H(2008)Functional outcome after language mapping for glioma resection N Engl J Med 358 18-27

[5] Sanai N(2011)Awake surgery for WHO Grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection Clin Article J Neurosurg 115 232-239

[6] Berger MS(2011)Clinical trial end points for high-grade glioma: the evolving landscape Neuro-Oncology 13 353-361

[7] Sanai N(2012)Cognitive outcome after awake surgery for tumors in language areas J Neurooncol 108 319-326

[8] Mirzadeh Z(1997)Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office Eur J Cancer 33 20-28

[9] Berger MS(2005)NIHSS score and arteriographic findings in acute ischemic stroke Stroke 36 2121-2125

[10] Yordanova YN(1999)The reliability of stroke scales. The german version of NIHSS, ESS and Rankin scales Fortschr Neurol Psychiatr 67 81-93

[1] Stummer W(2006)Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol 7 392-401

[2] Pichlmeier U(2012)The challenge to remove diffuse low-grade gliomas while preserving brain functions Acta Neurochir (Wien) 154 569-574

[3] Meinel T(2008)Glioma extent of resection and its impact on patient outcome Neurosurgery 62 753-764

[4] Duffau H(2008)Functional outcome after language mapping for glioma resection N Engl J Med 358 18-27

[5] Sanai N(2011)Awake surgery for WHO Grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection Clin Article J Neurosurg 115 232-239

[6] Berger MS(2011)Clinical trial end points for high-grade glioma: the evolving landscape Neuro-Oncology 13 353-361

[7] Sanai N(2012)Cognitive outcome after awake surgery for tumors in language areas J Neurooncol 108 319-326

[8] Mirzadeh Z(1997)Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office Eur J Cancer 33 20-28

[9] Berger MS(2005)NIHSS score and arteriographic findings in acute ischemic stroke Stroke 36 2121-2125

[10] Yordanova YN(1999)The reliability of stroke scales. The german version of NIHSS, ESS and Rankin scales Fortschr Neurol Psychiatr 67 81-93